New Delhi, Oct 2026 : Sleep deprivation, irregular daily routines and excessive physical activities may significantly increase the risk of migraine attacks among children, highlighting the importance of healthy lifestyle habits in managing recurring headaches, medical experts have said.
Paediatric migraine is influenced by several factors, including inadequate sleep, disrupted schedules, prolonged activities and insufficient rest. Specialists emphasise that recognising individual migraine triggers and establishing consistent daily routines can help reduce the frequency of attacks in children.
However, identifying these triggers is not always easy, as children's habits are closely linked to family schedules, school commitments and social activities.
One of the first challenges in childhood migraine management is helping parents understand the relationship between their children's daily routines and headache episodes. For children who experience migraines only a few times a year, identifying the precise triggers may require repeated discussions with parents and careful observation of their activities.
Staying awake late due to excitement, exhausting travel schedules, participating in prolonged activities without adequate breaks and the early stages of an illness can potentially contribute to migraine attacks.
Young children may also find it difficult to describe early warning symptoms or visual disturbances associated with migraine, commonly known as aura. As a result, parents may fail to recognise signs such as unusual tiredness and fatigue that could appear before a headache develops.
For children experiencing migraine attacks once or twice a month or more frequently, identifying individual triggers can become even more complicated. Persistent sleep deprivation and overcrowded daily schedules may create conditions in which several potential triggers overlap.
Lifestyle changes as the first step in migraine prevention
Although scientific evidence supporting lifestyle interventions specifically for paediatric migraine remains limited, specialists continue to recommend routine changes as an important initial approach before considering preventive medication.
A review by neurologists titled 'Lifestyle Advice for Pediatric Migraine: Blaming the Patient, or Evidence Based?' examined the challenges associated with lifestyle recommendations and the available scientific evidence.
Medical experts acknowledge that preventive medicines also have limitations. A recent review of 40 studies involving more than 2,500 patients found that approximately 30 per cent experienced at least one adverse event associated with preventive migraine medication.
The Childhood and Adolescent Migraine Prevention (CHAMP) trial, conducted between 2012 and 2018, compared the effectiveness of amitriptyline, topiramate and a placebo among children and adolescents over 24 weeks. The findings showed no significant difference between the three groups in achieving at least a 50 per cent reduction in monthly migraine days.
These findings underline the need for more effective and safer treatment options for childhood migraine.
Rising prevalence of migraine among children
Childhood migraine has emerged as an increasing public health concern, with studies indicating a rise in its prevalence over recent decades.
A Finnish study found that migraine prevalence among seven-year-old children increased from 14.4 per cent in 1974 to 51.5 per cent in 1992.
Another analysis published in 2025, based on Global Burden of Disease data, estimated that the incidence of childhood migraine increased from 22 per cent in 1990 to 36.8 per cent in 2021.
Researchers are also exploring the biological mechanisms behind migraine attacks, particularly the role of a molecule known as calcitonin gene-related peptide (CGRP).
CGRP is a neuropeptide found throughout the sensory nervous system and is believed to play an important role in migraine development. Studies suggest that blocking its activity could help prevent or stop migraine attacks.
An animal study involving sleep-restricted rats found that exposure to even low levels of CGRP triggered migraine-like behaviour. Rats that had not experienced sleep restriction did not show a similar response. Other animal studies have also indicated that lifestyle-related stressors associated with migraine may act through biological pathways involving CGRP.
New migraine medicines offer research possibilities
A newer class of migraine medicines, known as gepants, works by blocking CGRP-related activity. These drugs initially appeared to offer a better safety profile than some traditional treatments.
However, the US Food and Drug Administration has recently required warnings about new-onset and worsening hypertension associated with certain medicines in this category. Gepants are currently not approved for children and adolescents.
Researchers hope that further studies into CGRP and its role in migraine development will eventually lead to treatments that are more effective and cause fewer side effects than existing preventive medications.
Until then, specialists recommend that parents focus on maintaining regular sleep schedules, ensuring adequate rest and avoiding excessive daily activities. Observing children's routines, recognising early warning signs and consulting healthcare professionals can help identify individual migraine triggers.
Experts stress that childhood migraine is influenced by multiple factors, including individual biological and potentially genetic vulnerabilities. Parents should therefore avoid assuming that every headache has the same cause and seek professional guidance to develop an appropriate management plan.
(Disclaimer :The content of this article is sourced from a news agency and has not been edited by the Mavericknews30 team.)
Disclaimer: This article is intended for general informational and educational purposes only. It does not constitute medical advice, diagnosis or treatment. Migraine symptoms and triggers may vary from child to child. Parents should consult a qualified healthcare professional for proper evaluation and treatment. Do not start, stop or change any medication without medical advice.
